216 related articles for article (PubMed ID: 21842413)
1. Glycolysis inhibition by 2-deoxy-D-glucose reverts the metastatic phenotype in vitro and in vivo.
Sottnik JL; Lori JC; Rose BJ; Thamm DH
Clin Exp Metastasis; 2011 Dec; 28(8):865-75. PubMed ID: 21842413
[TBL] [Abstract][Full Text] [Related]
2. Suppression of oxidative phosphorylation confers resistance against bevacizumab in experimental glioma.
Eriksson JA; Wanka C; Burger MC; Urban H; Hartel I; von Renesse J; Harter PN; Mittelbronn M; Steinbach JP; Rieger J
J Neurochem; 2018 Feb; 144(4):421-430. PubMed ID: 29178334
[TBL] [Abstract][Full Text] [Related]
3. Acute myeloid leukemia sensitivity to metabolic inhibitors: glycolysis showed to be a better therapeutic target.
Lapa B; Gonçalves AC; Jorge J; Alves R; Pires AS; Abrantes AM; Coucelo M; Abrunhosa A; Botelho MF; Nascimento-Costa JM; Sarmento-Ribeiro AB
Med Oncol; 2020 Jul; 37(8):72. PubMed ID: 32725458
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of glioblastoma tumorspheres by combined treatment with 2-deoxyglucose and metformin.
Kim EH; Lee JH; Oh Y; Koh I; Shim JK; Park J; Choi J; Yun M; Jeon JY; Huh YM; Chang JH; Kim SH; Kim KS; Cheong JH; Kim P; Kang SG
Neuro Oncol; 2017 Feb; 19(2):197-207. PubMed ID: 27571886
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of Src phosphorylation alters metastatic potential of osteosarcoma in vitro but not in vivo.
Hingorani P; Zhang W; Gorlick R; Kolb EA
Clin Cancer Res; 2009 May; 15(10):3416-22. PubMed ID: 19447875
[TBL] [Abstract][Full Text] [Related]
6. Carboxyamidotriazole inhibits oxidative phosphorylation in cancer cells and exerts synergistic anti-cancer effect with glycolysis inhibition.
Ju R; Guo L; Li J; Zhu L; Yu X; Chen C; Chen W; Ye C; Zhang D
Cancer Lett; 2016 Jan; 370(2):232-41. PubMed ID: 26522259
[TBL] [Abstract][Full Text] [Related]
7. MiR-9 is overexpressed in spontaneous canine osteosarcoma and promotes a metastatic phenotype including invasion and migration in osteoblasts and osteosarcoma cell lines.
Fenger JM; Roberts RD; Iwenofu OH; Bear MD; Zhang X; Couto JI; Modiano JF; Kisseberth WC; London CA
BMC Cancer; 2016 Oct; 16(1):784. PubMed ID: 27724924
[TBL] [Abstract][Full Text] [Related]
8. p53 is an important factor for the radiosensitization effect of 2-deoxy-D-glucose.
Sinthupibulyakit C; Grimes KR; Domann FE; Xu Y; Fang F; Ittarat W; St Clair DK; St Clair W
Int J Oncol; 2009 Sep; 35(3):609-15. PubMed ID: 19639181
[TBL] [Abstract][Full Text] [Related]
9. Low-dose 2-deoxy glucose stabilises tolerogenic dendritic cells and generates potent in vivo immunosuppressive effects.
Christofi M; Le Sommer S; Mölzer C; Klaska IP; Kuffova L; Forrester JV
Cell Mol Life Sci; 2021 Mar; 78(6):2857-2876. PubMed ID: 33074350
[TBL] [Abstract][Full Text] [Related]
10. Effects of metabolic inhibition on conduction, Ca transients, and arrhythmia vulnerability in embryonic mouse hearts.
Chen F; De Diego C; Xie LH; Yang JH; Klitzner TS; Weiss JN
Am J Physiol Heart Circ Physiol; 2007 Oct; 293(4):H2472-8. PubMed ID: 17660398
[TBL] [Abstract][Full Text] [Related]
11. 2-Deoxyglucose induces the expression of thioredoxin interacting protein (TXNIP) by increasing O-GlcNAcylation - Implications for targeting the Warburg effect in cancer cells.
Hong SY; Hagen T
Biochem Biophys Res Commun; 2015 Oct; 465(4):838-44. PubMed ID: 26315267
[TBL] [Abstract][Full Text] [Related]
12. circPVT1 promotes osteosarcoma glycolysis and metastasis by sponging miR-423-5p to activate Wnt5a/Ror2 signaling.
Wan J; Liu Y; Long F; Tian J; Zhang C
Cancer Sci; 2021 May; 112(5):1707-1722. PubMed ID: 33369809
[TBL] [Abstract][Full Text] [Related]
13. One-stop radiotherapeutic targeting of primary and distant osteosarcoma to inhibit cancer progression and metastasis using 2DG-grafted graphene quantum dots.
Tung FI; Zheng LJ; Hou KT; Chiang CS; Chen MH; Liu TY
Nanoscale; 2020 Apr; 12(16):8809-8818. PubMed ID: 32250377
[TBL] [Abstract][Full Text] [Related]
14. A requirement for autophagy in HMGA2-induced metabolic reprogramming to support Cd-induced migration.
Hasenbilige ; Mei J; Dlamini MB; Gao Z; Jiang L; Li Q; Geng C; Shi X; Liu Y; Kong Y; Cao J
Toxicology; 2021 Oct; 462():152928. PubMed ID: 34481905
[TBL] [Abstract][Full Text] [Related]
15. Opposing effects of 2-deoxy-d-glucose on interictal- and ictal-like activity when K
Nedergaard S; Andreasen M
J Neurophysiol; 2018 May; 119(5):1912-1923. PubMed ID: 29412775
[TBL] [Abstract][Full Text] [Related]
16. Glycolysis inhibitor 2-deoxy-D-glucose suppresses carcinogen-induced rat hepatocarcinogenesis by restricting cancer cell metabolism.
Wang Z; Zhang L; Zhang D; Sun R; Wang Q; Liu X
Mol Med Rep; 2015 Mar; 11(3):1917-24. PubMed ID: 25394852
[TBL] [Abstract][Full Text] [Related]
17. Synergistic Anticancer Action of Lysosomal Membrane Permeabilization and Glycolysis Inhibition.
Kosic M; Arsikin-Csordas K; Paunovic V; Firestone RA; Ristic B; Mircic A; Petricevic S; Bosnjak M; Zogovic N; Mandic M; Bumbasirevic V; Trajkovic V; Harhaji-Trajkovic L
J Biol Chem; 2016 Oct; 291(44):22936-22948. PubMed ID: 27587392
[TBL] [Abstract][Full Text] [Related]
18. Dynamic analysis of lung metastasis by mouse osteosarcoma LM8: VEGF is a candidate for anti-metastasis therapy.
Tanaka T; Yui Y; Naka N; Wakamatsu T; Yoshioka K; Araki N; Yoshikawa H; Itoh K
Clin Exp Metastasis; 2013 Apr; 30(4):369-79. PubMed ID: 23076771
[TBL] [Abstract][Full Text] [Related]
19. 2-deoxy-D-Glucose Synergizes with Doxorubicin or L-Buthionine Sulfoximine to Reduce Adhesion and Migration of Breast Cancer Cells.
Mustafa EH; Mahmoud HT; Al-Hudhud MY; Abdalla MY; Ahmad IM; Yasin SR; Elkarmi AZ; Tahtamouni LH
Asian Pac J Cancer Prev; 2015; 16(8):3213-22. PubMed ID: 25921122
[TBL] [Abstract][Full Text] [Related]
20. Co-treatment of breast cancer cells with pharmacologic doses of 2-deoxy-D-glucose and metformin: Starving tumors.
Wokoun U; Hellriegel M; Emons G; Gründker C
Oncol Rep; 2017 Apr; 37(4):2418-2424. PubMed ID: 28350075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
